During the past decade, Wichita NCI Community Oncology Research Program conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 77 clinical trials were completed, i.e. on average, 592.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 34 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wichita NCI Community Oncology Research Program" #1 sponsor was "National Cancer Institute (NCI)" with 61 trials, followed by "SWOG Cancer Research Network" with 15 trials sponsored, "Gynecologic Oncology Group" with 9 trials sponsored, "GOG Foundation" with 4 trials sponsored and "Alliance for Clinical Trials in Oncology" with 4 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wichita NCI Community Oncology Research Program" #1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Wichita NCI Community Oncology Research Program" are "Recurrent Fallopian Tube Carcinoma" (7 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Recurrent Primary Peritoneal Carcinoma" (7 trials), "Ovarian Endometrioid Adenocarcinoma" (6 trials) and "Ovarian Seromucinous Carcinoma" (6 trials). Many other conditions were trialed in "Wichita NCI Community Oncology Research Program" in a lesser frequency.

Most popular intervention types in "Wichita NCI Community Oncology Research Program" are "Drug" (77 trials), "Other" (77 trials), "Biological" (41 trials), "Procedure" (14 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (60 trials), "Quality-of-Life Assessment" (26 trials), "Paclitaxel" (21 trials), "Bevacizumab" (17 trials) and "Carboplatin" (13 trials). Other intervention names were less common.

The vast majority of trials in "Wichita NCI Community Oncology Research Program" are 60 trials for "All" genders, 34 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Wichita NCI Community Oncology Research Program". undefined are not yet recruiting, undefined are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in Wichita NCI Community Oncology Research Program, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Wichita NCI Community Oncology Research Program, 5 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".